Expression of AITR and AITR ligand in breast cancer patients

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1189-1194

  Kim, Yon Seon ^a   Jung, Hyo Won ^b   Choi, Ji ^b   Kwon, Byung Sae ^b   Ham, Soo Youn ^c   Jung, Ae Kyung ^a   Ko, Byung Kyun ^a  

^a Ulsan University College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c Korea University Ansan Hospital   (South Korea)

Author keywords

Activation inducible tumor necrosis factor receptor; Activation inducible tumor necrosis factor receptor ligand; Breast cancer; Cancer cell; Soluble activation inducible tumor necrosis factor receptor; Tumor immunity

Indexed keywords

MESSENGER RNA; TNFSF18 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; CYTOLOGY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; MONOCYTE; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADULT; B-LYMPHOCYTES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; MONOCYTES; PHENOTYPE; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR NECROSIS FACTORS;

EID: 38449094242     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Aggarwal BB and Natarajan K: Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 7: 93-124, 1996. (Pubitemid 26144548)
2. Kwon B, Youn BS and Kwon BS: Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocutes. Curr Opin Immunol 11: 340-345, 1999. (Pubitemid 29263964)
3. Gurney P: General practice. Counsel homes. Health Serv J 109: 29, 1999.
4. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr and Sledge GW Jr: Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629-3639, 1997. (Pubitemid 27281838)
5. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB and Iglehart JD: NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA 101: 10137-10142, 2004. (Pubitemid 38891208)
6. Nocentini G, Giunchi L, Ronchetti S, Krausz LT, Bartoli A and Moraca R: A new member of the tumor necrosis factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci USA 94: 6216-6221, 1997. (Pubitemid 27270664)
7. Ronchetti S, Nocentini G, Riccardi C and Pandolfi PP: Role of GITR in activation response of T lymphocytes. Blood 100: 350-352, 2002. (Pubitemid 35177469)
8. Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101: 455-458, 2000.
9. Ermann J and Fathman CG: Costimulatory signals controlling regulatory T cells. Proc Natl Acad Sci USA 100: 15292-15293, 2003. (Pubitemid 38020981)
10. Kwon B, Kim BS, Cho HR, Park JE and Kwon BS: Involvement of tumor necrosis factor receptor superfamily (TNFRSF) members in the pathogenesis of inflammatory diseases. Exp Mol Med 35: 8-16, 2003. (Pubitemid 36336923)
11. Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM and Wang RF: Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20: 107-118, 2004. (Pubitemid 38134298)
12. Stephens GL, Mchugh RS, Whitters MJ, Young DA, Luxenberg D, Carreno BM, Collins M and Shevach EM: Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 173: 5008-5020, 2004. (Pubitemid 39387783)
13. Kim BJ, Li Z, Fariss RN, Shen de F, Mahesh SP, Egwuagu C, Yu CR, Nagineni CN, Chan CC and Nussenblatt RB: Constitutive and cytokine-induced GITR ligand expression on human retinal pigment epithelium and photoreceptors. Invest Ophthalmol Vis Sci 45: 3170-3176, 2004. (Pubitemid 39121852)
14. Dols A, Smith JW 2nd, Meijer SL, Fox BA, Hu HM, Walker E, Rosenheim S, Moudgil T, Doran T, Wood W, Seligman M, Alvord WG, Schoof D and Urba WJ: Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results. Hum Gene Ther 14: 1117-1123, 2003. (Pubitemid 36851402)
15. Fan P, Wang S, Liu X, Zhen L and Wu Z: Major histocompatibility complex class II antigen and costimulatory molecule expression on the surface of breast cancer cells. Zhonghua Zhong Liu Za Zhi 24: 327-330, 2002.
16. Dan HL, Zhao Y, Zhang J and Zhang JR: In vitro regulation of HLA and B7 expression in multidrug-resistant breast cancer cells. Di Yi Jun Yi Da Xue Xue Bao 22: 107-110, 2002.
17. Wolfram RM, Budinsky AC, Brodowicz T, Kubista M, Kostler WJ, Kichler-Lakomy C, Hellan M, Kahlhammer G, Wiltschke C and Zielinski CC: Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer. Int J Cancer 88: 239-244, 2000.
18. Komi J and Lassila O: Toremifene increase the expression of intercellur adhesion molecule-1 (ICAM-1) on MCF-7 breast cancer cells and Jurkat cells. Scand J Immunol 51: 73-78, 2000. (Pubitemid 30074306)
19. Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA and Freeman GJ: Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 170: 1257-1266, 2003. (Pubitemid 36139491)
20. Li Z, Mahesh SP, Kim BJ, Buggage RR and Nussenblatt RB: Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J Autoimmun 21: 83-92, 2003. (Pubitemid 36871690)
21. Chow SN, Lin MC, Shen J, Wang S, Jong YJ and Chien CH: Analysis of chromosome abnormalities by comparative genomic hybridization in malignant peripheral primitive neuroectodermal tumor of the ovary. Gynecol Oncol 92: 752-760, 2004. (Pubitemid 38251373)
22. Secchiero P, Vaccarezza M, Gonelli A and Zauli G: TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignancies. Curr Pharm 10: 3673-3681, 2004. (Pubitemid 39386582)
23. Ruberti G, Cascino I, Papoff G and Eramo A: Fas splicing variants and their effect on apoptosis. Adv Exp Med Biol 406: 125-134, 1996. (Pubitemid 26357348)
24. Folkman J: Angiogenesis and apoptosis. Semin Cancer Biol 13: 159-167, 2003.
25. Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, Godowski PJ, Wood WI, Gurney AL, Hillan KJ, Cohen RL, Goddard AD, Botstein D and Ashkenazi A: Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396: 699-703, 1998. (Pubitemid 29003951)
26. Bewick M, Conlon M, Parissenti AM, Lee H and Zhang L: Soluble Fas (CD95) is a prognostic factor in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous stem cell transplantation. J hematother Stem Cell Res 10: 759-768, 2001. (Pubitemid 34081304)
27. Hallermalm K, De Geer A, Kiessling R, Levitsky V and Levitskaya J: Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes. Cancer Res 64: 6775-6782, 2004. (Pubitemid 39297941)
28. Shin DH, Kwon BS, Chang YP, Bad SR, Kim J and Kim JW: Ultramicroscopical immunolocalization of PAX6 in the adult chicken retina. Acta Histochem 105: 267-272, 2003. (Pubitemid 37046260)
29. Ji HB, Liao G, Faubion WA, Abadia-Molina AC, Cozzo C, Laroux FS, Caton A and Terhorst C: Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 172: 5823-5827, 2004. (Pubitemid 38621178)
30. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H, Kraut N, Beug H and Wirth T: NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581, 2004. (Pubitemid 39572107)